These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 30771760)
21. The efficacy of a biopsy of intrinsic brainstem lesions for decision making of the treatments. Ogiwara H; Morota N Childs Nerv Syst; 2013 May; 29(5):833-7. PubMed ID: 23377758 [TBL] [Abstract][Full Text] [Related]
27. DIPG in Children - What Can We Learn from the Past? Vanan MI; Eisenstat DD Front Oncol; 2015; 5():237. PubMed ID: 26557503 [TBL] [Abstract][Full Text] [Related]
28. DNX-2401, an Oncolytic Virus, for the Treatment of Newly Diagnosed Diffuse Intrinsic Pontine Gliomas: A Case Report. Tejada S; Díez-Valle R; Domínguez PD; Patiño-García A; González-Huarriz M; Fueyo J; Gomez-Manzano C; Idoate MA; Peterkin J; Alonso MM Front Oncol; 2018; 8():61. PubMed ID: 29594041 [TBL] [Abstract][Full Text] [Related]
29. Immune Microenvironment and Immunotherapies for Diffuse Intrinsic Pontine Glioma. Chen Y; Zhao C; Li S; Wang J; Zhang H Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765560 [TBL] [Abstract][Full Text] [Related]
30. Deceptive morphologic and epigenetic heterogeneity in diffuse intrinsic pontine glioma. Bugiani M; Veldhuijzen van Zanten SEM; Caretti V; Schellen P; Aronica E; Noske DP; Vandertop WP; Kaspers GJL; van Vuurden DG; Wesseling P; Hulleman E Oncotarget; 2017 Sep; 8(36):60447-60452. PubMed ID: 28947983 [TBL] [Abstract][Full Text] [Related]
31. T2-FLAIR Mismatch Sign and Response to Radiotherapy in Diffuse Intrinsic Pontine Glioma. Yamasaki F; Nishibuchi I; Karakawa S; Kaichi Y; Kolakshyapati M; Takano M; Yonezawa U; Imano N; Taguchi A; Shimomura M; Taniguchi M; Onishi S; Okada S; Awai K; Sugiyama K; Nagata Y Pediatr Neurosurg; 2021; 56(1):1-9. PubMed ID: 33535215 [TBL] [Abstract][Full Text] [Related]
32. Diffuse intrinsic pontine gliomas in adults: A retrospective study. Kandregula S; Konar S; Sadashiva N; Nagesh M; Kalahasti SR; Krishna U; Saini J; Shukla D; Santosh V Neurol India; 2022; 70(2):584-590. PubMed ID: 35532623 [TBL] [Abstract][Full Text] [Related]
33. Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy. Lieberman NAP; DeGolier K; Kovar HM; Davis A; Hoglund V; Stevens J; Winter C; Deutsch G; Furlan SN; Vitanza NA; Leary SES; Crane CA Neuro Oncol; 2019 Jan; 21(1):83-94. PubMed ID: 30169876 [TBL] [Abstract][Full Text] [Related]
38. Intraarterial delivery of bevacizumab and cetuximab utilizing blood-brain barrier disruption in children with high-grade glioma and diffuse intrinsic pontine glioma: results of a phase I trial. McCrea HJ; Ivanidze J; O'Connor A; Hersh EH; Boockvar JA; Gobin YP; Knopman J; Greenfield JP J Neurosurg Pediatr; 2021 Oct; 28(4):371-379. PubMed ID: 34359048 [TBL] [Abstract][Full Text] [Related]
39. Anti-tumor efficacy of anti-GD2 CAR NK-92 cells in diffuse intrinsic pontine gliomas. Zuo P; Li Y; He C; Wang T; Zheng X; Liu H; Wu Z; Zhang J; Liao X; Zhang L Front Immunol; 2023; 14():1145706. PubMed ID: 37251413 [TBL] [Abstract][Full Text] [Related]
40. Pediatric diffuse intrinsic pontine glioma radiotherapy response prediction: MRI morphology and T2 intensity-based quantitative analyses. Yu X; Li S; Mai W; Hua X; Sun M; Lai M; Zhang D; Xiao Z; Wang L; Shi C; Luo L; Cai L Eur Radiol; 2024 Jun; ():. PubMed ID: 38907098 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]